This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Mereo Biopharma 1 Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Mark Meisenbach: Innovator in Synthetic Chemistry
Introduction
Mark Meisenbach is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of synthetic chemistry, particularly through his innovative patent. His work focuses on the preparation of complex chemical compounds, showcasing his expertise and dedication to advancing scientific knowledge.
Latest Patents
Mark Meisenbach holds a patent for a synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound. This patent outlines a process that involves reacting a compound of Formula A with another compound to yield a specific product. The patent emphasizes the utility of these compounds in further chemical synthesis, demonstrating their potential applications in various fields.
Career Highlights
Throughout his career, Mark has been associated with Mereo Biopharma 1 Limited, where he has contributed to the company's research and development efforts. His work has been instrumental in advancing the company's goals and enhancing its portfolio of innovative solutions.
Collaborations
Mark collaborates with talented professionals in his field, including Carmen Ruiz and Niek Johannes Ronde. These collaborations foster a dynamic environment for innovation and creativity, allowing for the exchange of ideas and expertise.
Conclusion
Mark Meisenbach's contributions to synthetic chemistry through his patent and work at Mereo Biopharma 1 Limited highlight his role as an influential inventor. His dedication to innovation continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile